Journal of Tuberculosis Research

Journal of Tuberculosis Research

ISSN Print: 2329-843X
ISSN Online: 2329-8448
www.scirp.org/journal/jtr
E-mail: jtr@scirp.org
"Risk Factors for Drug-Resistant Tuberculosis"
written by Marta Gomes, Ana Correia, Denisa Mendonça, Raquel Duarte,
published by Journal of Tuberculosis Research, Vol.2 No.3, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] The Role of Noncommunicable Diseases in the Pursuit of Global Health Security
2021
[2] Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
Jurnal Teknologi …, 2021
[3] Epidemiological Characteristics and Their Influencing Factors Among Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Survey Study …
Frontiers in Public …, 2021
[4] Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia
2020
[5] Increasing Burden of Multidrug Resistant Tuberculosis in HIV Infected Individuals: A Systematic Review and Meta-Analysis
2020
[6] Analysis of drug susceptibility patterns in tuberculosis diagnosed cases from Ecuador during 2012-2017
2020
[7] DETERMINATION OF MAJOR FACTORS PREDICTING MDRTB AMONG PRESUMPTIVE MDRTB CASES IN PLATEAU STATE–NIGERIA
2020
[8] RISK FACTORS FOR MULTI DRUG-RESISTANT TUBERCULOSIS AMONG TUBERCULOSIS PATIENTS OF NEKEMTE REFERRAL HOSPITAL, OROMIA REGIONAL STATE, WESTERN ETHIOPIA, 2017
Scientific Research and Reviews, 2019
[9] First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017
2019
[10] Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study
2019
[11] Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance
2019
[12] Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study
2019
[13] Association between DOTS program and the outcome of previous therapy in MDR-TB patients: a case study in Tasikmalaya district, West Java, Indonesia
2019
[14] RISK FACTORS FOR MULTI DR TUBERCULOSIS PATIENTS OF N REGIONAL STATE
2019
[15] Penanganan Tuberkulosis Resistan Obat pada Daerah Terpencil: Mission Impossible?
2019
[16] Karakteristike toka plućne tuberkuloze kod obolelih od šećerne bolesti
2019
[17] Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia
Thesis, 2019
[18] RISK FACTORS FOR MULTI DRUG-RESISTANT TUBERCULOSIS AMONG TUBERCULOSIS PATIENTS OF NEKEMTE REFERRAL HOSPITAL, OROMIA REGIONAL STATE, WESTERN ETHIOPIA
Scientific Research and Reviews, 2019
[19] Determinants of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients in Southern Ethiopia: A Case Control Study
2019
[20] Clinical Risk Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) in Mali
2019
[21] STRATEGIES THERAPEUTIQUES DU TRAITEMENT DE LA TUBERCULOSE PULMONAIRE ET LA TUBERCULOSE RESISTANTE CHEZ LA POPULATION …
2019
[22] HUBUNGAN ANTARA KEJADIAN MULTI-DRUG RESISTANT TUBERCULOSIS (TB-MDR) TERHADAP PENDERITA DIABETES MELITUS
JKM, 2019
[23] Kejadian Tuberkulosis Multi Drug Resistant di RSUP dr. Kariadi
2018
[24] ASSOCIATION OF MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS AND DIABETES MELLITUS
2018
[25] Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014–2015
2018
[26] TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR PRETREATMENT EVALUATION IN DOTS PLUS CENTRE, THANJAVUR
J. Evid. Based Med. Healthc., 2017
[27] Gambaran Karakteristik Pasien TB-MDR Dengan Diabetes Melitus di Rumah Sakit Umum Pusat Haji Adam Malik Medan Tahun 2016
2017
[28] Structural analysis of the mycobacterium tuberculosis redox defence network reveals a unique bi-fan motif design associated with hydrogen peroxide reduction.
2017
[29] Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia/Resistencia as drogas antituberculose na fronteira do Brasil com Paraguai e Bolivia
Revista Panamericana de Salud Publica, 2017
[30] Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan
2017
[31] Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan.
2017
[32] Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia
Resistência às drogas , 2017
[33] Assess drug resistance pattern and genetic profile of Mycobacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and IS6110 in pulmonary tuberculosis cases
Lung India, 2017
[34] Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security
Emerging infectious diseases, 2017
[35] Resistência às drogas antituberculose na fronteira do Brasil com Paraguai e Bolívia
2017
[36] Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia/Resistencia as drogas antituberculose na fronteira do Brasil com Paraguai e Bolivia.
2017
[37] Evaluation Of Management, Treatment Outcomes And Health Related Quality Of Life Of Multidrug Resistant Tuberculosis Patients In Peshawar, Pakistan
2016
[38] Evaluating related factors with sputum smear negation at the end of the second month of tuberculosis treatment
2016
[39] Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan
PloS one, 2016
[40] ارزیابی عوامل مرتبط بر منفی شدن اسمیر خلط بیماران سل ریوی در پایان ماه دوم درمان‎
2016
[41] Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis, 2016
[42] Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia
2016
[43] Prevalence and Genetic Variation among Drug Resistance Genes of Mycobacterium tuberculosis
2015
[44] Treatment Outcome of Drug Resistant Tuberculosis Patients of Kashmir Valley by Molecular Assays: A prospective study
[45] Risk Factor Identification of Multi-Drug Resistant Tuberculosis
[46] TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR …
N Kuppusamy, M Arjunan, U Nagarajan
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top